Abstract
Kyle Grant is a trained PhD chemical engineer with a concentration in molecular virology. Kyle has extensive experience in the molecular analysis of virus host cell interactions, as well as innovation around commercial grade unit operations to support CMC activities for the application of viral vectors in gene therapy. This multi-scale approach allows for comprehensive insight into the development of methods for provision and release of novel drug candidates to address the unmet need for patients where there is no available cure.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
